Pirfenidone - Isotope Labelled Standards
References
FAQ's
References
- Gadekar, Shreekrishna M., N-Substituted Pyridone and General Method For Preparing Pyridones, Affiliated Medical Research, Inc., United States, US3839346A, October 1, 1974
- Shi, Shaojun; Wu, Jianhong; Wu, Jun; Zeng, Fandian, Development and Validation of an Improved LC Method for the Simultaneous Determination of Pirfenidone and Its Carboxylic Acid Metabolite in Human Plasma, Chromatographia, Volume: 69, Issue: 5-6, Pages: 459-463, 2009
Frequently Asked Questions
How effectively can Pirfenidone impurities be removed?
Rigorous purification techniques help minimize Pirfenidone impurities significantly and ensure its quality.
What is the significance of analyzing Pirfenidone impurities?
Pirfenidone impurities analysis verifies the drug's purity, safety, and efficacy in treating lung illnesses and fibrosis.
How are Pirfenidone impurities synthesized?
The synthetic process of Pirfenidone impurities involves specific chemical reactions and methods during the manufacturing of the drug.
What are the temperature conditions required to store Pirfenidone impurities?
Pirfenidone impurities should ideally be stored at a controlled room temperature of 2-8°C or as described on the Certificate of Analysis (CoA).
Note: Products protected by valid patents by a manufacturer are not offered for sale in countries having patent protection. The sale of such products constitutes a patent infringement, and its liability is at the buyer's risk.